GENE News and Press, Genetic Technologies Ltd From 12/21/21

Forecast 2QFY22 1 cash receipts +112% versus the prior quarter (1QFY22) to A$1.8 million following the completed integration of EasyDNA in the quarter Multi-Test technical validation complete and submitted to NATA 2 and CMS 3 for final regulatory approval ahead of the co...

MELBOURNE, Australia, Dec. 10, 2021 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”, “GENE”), a global leader in genomics-based tests in health, wellness and serious disease confirms that the Company’s Director of Clinic...

Genetic Technologies (NASDAQ:GENE) confirms that its U.S. patent application for novel geneType COVID-19 Risk Test has been accepted. GENE shares up 3.6% premarket at $2.33. Formalities will be reviewed and a formal report will be provided within next 10 days which will include the ...

MELBOURNE, Australia, Dec. 09, 2021 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”, “GENE”), a global leader in genomics-based tests in health, wellness and serious disease confirms that the Company’s US patent applicat...

MELBOURNE, Australia, Oct. 25, 2021 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”, “GTG”), a global leader in Genomics based tests in health, wellness and serious disease provides its results for its first quarter of fiscal y...

Genetec Q2FY2022 PAT Up by Sixfold BANGI, Malaysia, Oct 25, 2021 - (ACN Newswire) - Genetec Technology Berhad ("Genetec" or the "Company"), a technology leader in providing customised full turnkey smart factory automation manufacturing lines, today announced that the Company r...

FinancialBuzz.com’s latest The Buzz Show: Featuring Our Corporate News Recap on “OpGen, Inc. Receives FDA Clearance for Acuitas® AMR Gene Panel” OpGen, Inc. (NASDAQ: OPGN) surged over 25% in premarket trading after the company received the...

MELBOURNE, Australia, Oct. 04, 2021 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”, “GENE”), a global leader in genomics-based tests in health, wellness and serious disease, announces a 12-fold increase in revenue generated du...

MELBOURNE, Australia, Sept. 30, 2021 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”, “GTG”), a global leader in Genomics based tests in health, wellness and serious disease, today announced that an interview with CEO ...

MELBOURNE, Australia, Sept. 28, 2021 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”, “GTG”), a diversified Genomics and AI driven preventative health business today announced that they have entered into a strategic collaborati...